Cargando…
Assessing the Impact of a Novel Smartphone Application Compared With Standard Follow-Up on Mobility of Patients With Knee Osteoarthritis Following Treatment With Hylan G-F 20: A Randomized Controlled Trial
BACKGROUND: Osteoarthritis (OA) is a leading cause of disability in the United States. Although no disease-modifying therapies exist, patients with knee OA who increase walking may reduce risk of functional limitations. OBJECTIVE: The objective of the study is to evaluate the impact of a mobile app...
Autores principales: | Skrepnik, Nebojsa, Spitzer, Andrew, Altman, Roy, Hoekstra, John, Stewart, John, Toselli, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442351/ https://www.ncbi.nlm.nih.gov/pubmed/28487266 http://dx.doi.org/10.2196/mhealth.7179 |
Ejemplares similares
-
Incorporating Novel Mobile Health Technologies Into Management of Knee Osteoarthritis in Patients Treated With Intra-Articular Hyaluronic Acid: Rationale and Protocol of a Randomized Controlled Trial
por: Jones, Donald, et al.
Publicado: (2016) -
Viscosupplementation for knee osteoarthritis: a focus on Hylan G-F 20
por: Webb, David, et al.
Publicado: (2018) -
Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritis
por: Migliore, Alberto, et al.
Publicado: (2019) -
Hylan GF-20 Viscosupplementation in the Treatment of Symptomatic Osteoarthritis of the Knee: Clinical Effect Survivorship at 5 Years
por: Boutefnouchet, Tarek, et al.
Publicado: (2017) -
Total Knee Replacement Delayed With Hylan G-F 20 Use in Patients With Grade IV Osteoarthritis
por: Waddell, David D., et al.
Publicado: (2007)